Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Gift of 405,880 ANTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | AN2 Therapeutics, Inc. (ANTX) | Gift | 405,880 | n/a |
| Mar 23, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 99,999 | n/a |
| Feb 23, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 20,400 | n/a |
| May 23, 2025 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 19,111 | n/a |
| Apr 11, 2025 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 10,523 | n/a |
| Dec 23, 2024 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 9,816 | n/a |
| Nov 27, 2024 | AN2 Therapeutics, Inc. (ANTX) | Purchase | 2,000 | $2.8K |
| Nov 20, 2024 | AN2 Therapeutics, Inc. (ANTX) | Purchase | 20,000 | $20.0K |
| Jun 21, 2024 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 64,503 | n/a |
| Feb 8, 2024 | Cyteir Therapeutics, Inc. (CYT) | Exercise/Conversion | 14,150 | $23.9K |